How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?

Philippe Büscher, Stijn Deborggraeve

    Research output: Contribution to journalA1: Web of Science-article

    Abstract

    A variety of molecular diagnostic tests for human African trypanosomiasis (HAT) (sleeping sickness) has been developed. Some are effectively used for research and confirmation diagnosis in travel medicine, usually following non-standardized protocols. Others have become commercially available as diagnostic kits. WHO aims to eliminate HAT as a public health problem by the year 2020, and zero transmission by the year 2030. This article gives an overview of the recent progress in molecular diagnostics for sleeping sickness, including the most recent data on test performances. Also discussed is how molecular diagnostics can play an important role in the process toward the elimination of HAT.

    Original languageEnglish
    JournalExpert Review of Molecular Diagnostics
    Volume15
    Issue number5
    Pages (from-to)607-615
    Number of pages9
    ISSN1473-7159
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Dive into the research topics of 'How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?'. Together they form a unique fingerprint.

    Cite this